← FDA DRUG APPROVALS

FDA ANDA · ANDA072080

FUROSEMIDE

Sponsor: HOSPIRA

APPLICATION
ANDA072080
TYPE
ANDA
ORIGINAL APPROVAL
1991-08-13
LATEST ACTION
2001-02-14
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

FUROSEMIDEDiscontinued
FUROSEMIDE 10MG/ML · INJECTABLE · INJECTION

Approval history

2001-02-14Manufacturing (CMC) · Supplement 9AP
1997-08-12Labeling · Supplement 8AP
1995-12-22Manufacturing (CMC) · Supplement 7AP
1993-03-09Labeling · Supplement 4AP
1992-07-09Labeling · Supplement 2AP
1991-08-13OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →